Cutaneous large B-cell lymphoma of the leg masquerading as a chronic venous ulcer

British Journal of Dermatology

Volumn 146, Issue 1, 2002, Pages 144-147

  Garbea, A ^a   Dippel, E ^a   Hildenbrand, R ^a   Bleyl, U ^a   Schadendorf, D ^a   Goerdt, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anti CD20 monoclonal antibody therapy; Cutaneous B cell lymphoma; Radiotherapy; Rituximab; Ulcers

Indexed keywords

RITUXIMAB;

AGED; ARTICLE; B CELL LYMPHOMA; BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; ELECTRON BEAM; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LEG ULCER; LYMPHADENOPATHY; PHOTOTHERAPY; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN LYMPHOMA; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LYMPHOMA, B-CELL; REMISSION INDUCTION; SKIN NEOPLASMS; VARICOSE ULCER;

EID: 0036178593     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-0963.2001.04520.x     Document Type: Article

References (28)

1. Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas
2. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
3. Primary cutaneous follicular center cell lymphoma: Clinical and histological aspects
4. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: A clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy
5. Primary cutaneous B-cell lymphoma: A clinically homogeneous entity?
6. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis
7. The morphologic spectrum of cutaneous B-cell lymphomas
8. Primary B-cell lymphomas of the skin
9. Therapy of primary cutaneous B-cell lymphomas
10. The role of immunohistochemistry in the diagnosis of cutaneous lymphoma
11. Use of rituximab, the new FDA-approved antibody
12. Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma
13. Newer treatments for non-Hodgkin's lymphoma: Monoclonal antibodies
14. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
15. Clinical status and optimal use of rituximab for B-cell lymphomas
16. EORTC classification for primary cutaneous lymphomas: The best guide to good clinical management
17. Primary cutaneous large B-cell lymphoma. The relation between morphology, clinical presentation, immunohistochemical markers and survival
18. IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma
19. Rituximab therapy in Waldenstrom's macroglobulinemia: Preliminary evidence of clinical activity
20. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
21. Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma
22. Rituximab in cutaneous B-cell lymphoma: A report of two cases
23. Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
24. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma
25. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study
26. Primary cutaneous B-cell lymphoma: A unique type of low-grade lymphoma. Clinico-pathologic and immunologic study of 83 cases
27. Radiotherapy of cutaneous B cell lymphomas: Our experience in 31 cases
28. Radiotherapy in the management of cutaneous B-cell lymphoma. Our experience in 25 cases